Skip to main content
BioCryst Pharmaceuticals, Inc. (BCRX)
NASDAQ: BCRX · Real-Time Price · USD
8.53
+0.18 (2.16%)
At close: Aug 13, 2025, 4:00 PM
8.49
-0.04 (-0.47%)
After-hours: Aug 13, 2025, 5:54 PM EDT

BioCryst Pharmaceuticals Revenue by Segment
Period Ending Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022
Orladeyo
531.59M 483.04M 437.66M 404.36M 373.72M 346.44M 325.99M 305.84M
Orladeyo Growth
42.24% 39.43% 34.26% 32.21% 30.61% 28.15% 29.55% -
Other
25.92M 20.45M 13.05M 8.22M 8.51M 8.95M 5.42M 11.72M
Other Growth
204.45% 128.43% 140.72% -29.82% -58.49% -53.71% -71.75% -

Revenue by Type
Period Ending Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022
Product
551.63M 497.18M 442.67M 404.06M 373.29M 345.80M 324.70M 312.02M
Product Growth
47.78% 43.78% 36.33% 29.50% 23.63% 20.77% 21.29% -
Collaborative and Other
5.88M 6.30M 8.04M 8.52M 8.95M 9.59M 6.72M 5.54M
Collaborative and Other Growth
-34.31% -34.31% 19.77% 53.86% 90.65% 186.19% 115.46% -

Revenue by Geography
Period Ending Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022
United States
470.58M 426.15M 385.96M 358.41M 330.57M 307.48M 288.36M 272.55M
United States Growth
42.36% 38.60% 33.85% 31.50% 28.43% 26.39% 27.39% -
Outside of US
61.00M 56.88M 51.70M 45.94M 43.15M 38.97M 37.63M 33.29M
Outside of US Growth
41.37% 45.98% 37.39% 38.00% 50.14% 43.94% 48.88% -
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.